THC TENET HEALTHCARE CORP revenue, earnings and financials

For the quarter ended June 30, 2026, TENET HEALTHCARE CORP reported revenue of $5.63B (up 6.8% from a year earlier), net income of $1.05B and diluted EPS of $9.84; over the last four quarters revenue was $21.8B and net income $3.17B; for the fiscal year ended December 2025 revenue was $21.3B, up 3.1% on the year before.

THC annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $21.3B, gross profit n/a, operating income $3.51B, net income $2.37B (margin 11.1%), EPS $15.49
• Fiscal year ended Dec 2024: revenue $20.7B, gross profit n/a, operating income $5.96B, net income $4.06B (margin 19.7%), EPS $32.70
• Fiscal year ended Dec 2023: revenue $20.6B, gross profit n/a, operating income $2.51B, net income $1.31B (margin 6.4%), EPS $5.71
• Fiscal year ended Dec 2022: revenue $19.2B, gross profit n/a, operating income $2.33B, net income $1.00B (margin 5.2%), EPS $3.79
• Fiscal year ended Dec 2021: revenue $19.5B, gross profit n/a, operating income $2.87B, net income $1.48B (margin 7.6%), EPS $8.42

THC quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $5.63B (up 6.8% year over year), net income $1.05B, EPS $9.84
• Quarter ended Mar 31, 2026: revenue $5.37B (up 2.8% year over year), net income $906M, EPS $8.01
• Quarter ended Dec 31, 2025 (from the annual report): revenue $5.53B (up 8.9% year over year), net income $644M, EPS $4.22
• Quarter ended Sep 30, 2025: revenue $5.29B (up 3.2% year over year), net income $579M, EPS $3.86
• Quarter ended Jun 30, 2025: revenue $5.27B (up 3.2% year over year), net income $522M, EPS $3.14
• Quarter ended Mar 31, 2025: revenue $5.22B (down 2.7% year over year), net income $622M, EPS $4.27
• Quarter ended Dec 31, 2024 (from the annual report): revenue $5.07B (down 6.0% year over year), net income $572M, EPS $3.79
• Quarter ended Sep 30, 2024: revenue $5.13B (up 1.2% year over year), net income $681M, EPS $4.89
• Quarter ended Jun 30, 2024: revenue $5.11B (up 0.5% year over year), net income $477M, EPS $2.64
• Quarter ended Mar 31, 2024: revenue $5.37B (up 6.9% year over year), net income $2.33B, EPS $21.38
• Quarter ended Dec 31, 2023 (from the annual report): revenue $5.40B (up 8.1% year over year), net income $456M, EPS $2.30
• Quarter ended Sep 30, 2023: revenue $5.07B (up 5.5% year over year), net income $266M, EPS $0.94
• Quarter ended Jun 30, 2023: revenue $5.08B (up 9.6% year over year), net income $293M, EPS $1.15
• Quarter ended Mar 31, 2023: revenue $5.02B (up 5.8% year over year), net income $296M, EPS $1.32
• Quarter ended Dec 31, 2022 (from the annual report): revenue $4.99B (up 2.8% year over year), net income $274M, EPS $1.00
• Quarter ended Sep 30, 2022: revenue $4.80B (down 1.9% year over year), net income $268M, EPS $1.16
• Quarter ended Jun 30, 2022: revenue $4.64B (down 6.4% year over year), net income $179M, EPS $0.35
• Quarter ended Mar 31, 2022: revenue $4.75B (down 0.8% year over year), net income $280M, EPS $1.28
• Quarter ended Dec 31, 2021 (from the annual report): revenue $4.86B, net income $419M, EPS $2.29
• Quarter ended Sep 30, 2021: revenue $4.89B, net income $578M, EPS $4.13

THC cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $3.54B, share buybacks $1.39B
• Fiscal year ended Dec 2024: operating cash flow $2.05B, share buybacks $672M
• Fiscal year ended Dec 2023: operating cash flow $2.37B, share buybacks $200M
• Fiscal year ended Dec 2022: operating cash flow $1.08B, share buybacks $250M
• Fiscal year ended Dec 2021: operating cash flow $1.57B, share buybacks $0

THC balance sheet

• Jun 30, 2026: cash $2.17B, total assets $30.7B, total liabilities $22.0B, shareholders' equity $4.66B
• Mar 31, 2026: cash $2.97B, total assets $31.2B, total liabilities $22.4B, shareholders' equity $4.81B
• Dec 31, 2025: cash $2.88B, total assets $29.7B, total liabilities $20.7B, shareholders' equity $4.22B
• Sep 30, 2025: cash $2.98B, total assets $29.4B, total liabilities $20.7B, shareholders' equity $4.01B
• Jun 30, 2025: cash $2.63B, total assets $28.7B, total liabilities $20.4B, shareholders' equity $3.75B
• Mar 31, 2025: cash $3.00B, total assets $29.2B, total liabilities $20.6B, shareholders' equity $4.18B
• Dec 31, 2024: cash $3.02B, total assets $28.9B, total liabilities $20.4B, shareholders' equity $4.17B
• Sep 30, 2024: cash $4.09B, total assets $29.4B, total liabilities $21.3B, shareholders' equity $3.83B

What is THC's revenue?

TENET HEALTHCARE CORP reported $21.8B of revenue over its last four quarters, through June 30, 2026.

Is THC profitable?

Yes. TENET HEALTHCARE CORP earned $3.17B over the last four quarters.

What is THC's EPS?

Diluted earnings per share over the last four quarters were $25.93; $9.84 in the latest quarter.

THC ownership and insider trades · All stocks